Multiple effects of codon usage optimization on expression and immunogenicity of DNA candidate vaccines encoding the human immunodeficiency virus type 1 Gag protein

被引:155
作者
Deml, L
Bojak, A
Steck, S
Graf, M
Wild, J
Schirmbeck, R
Wolf, H
Wagner, R
机构
[1] Univ Regensburg, Inst Med Microbiol, D-93053 Regensburg, Germany
[2] Univ Ulm, Inst Med Microbiol & Immunol, D-89069 Ulm, Germany
关键词
D O I
10.1128/JVI.75.22.10991-11001.2001
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
We have analyzed the influence of codon usage modifications on the expression levels and immunogenicity of DNA vaccines, encoding the human immunodeficiency virus type 1 (HIV-1) group-specific antigen (Gag). In the presence of Rev, an expression vector containing the Mid-type (wt) gag gene flanked by essential cis-acting sites such as the 5'-untranslated region and 3'-Rev response element supported substantial Gag protein expression and secretion in human H1299 and monkey COS-7 cells. However, only weak Gag production was observed from the murine muscle cell line C2C12. In contrast, optimization of the Gag coding sequence to that of highly expressed mammalian genes (syngag) resulted in an obvious increase in the G+C content and a Rev-independent expression and secretion of Gag in all tested mammalian cell lines, including murine C2C12 muscle cells. Mice immunized intramuscularly with the syngag plasmid showed Th1-driven humoral and cellular responses that were substantially higher than those obtained after injection of the Rev-dependent wild-type (wt) gag vector system. In contrast, intradermal immunization of both wt gag and syngag vector systems with the particle gun induced a Th2-biased antibody response and no cytotoxic T lymphocytes. Deletion analysis demonstrated that the CpG motifs generated within syngag by codon optimization do not contribute significantly to the high immunogenicity of the syngag plasmid. Moreover, low doses of coadministered stimulatory phosphorothioate oligodeoxynucleotides (ODNs) had only a weak effect on antibody production, whereas at higher doses immunostimulatory and nonstimulatory ODNs showed a dose-dependent suppression of humoral responses. These results suggest that increased Gag expression, rather than modulation of CpG-driven vector immunity, is responsible for the enhanced immunogenicity of the syngag DNA vaccine.
引用
收藏
页码:10991 / 11001
页数:11
相关论文
共 43 条
  • [1] André S, 1998, J VIROL, V72, P1497
  • [2] Cross-clade human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocyte responses in HIV-infected Zambians
    Betts, MR
    Krowka, J
    Santamaria, C
    Balsamo, K
    Gao, F
    Mulundu, G
    Luo, CW
    NGandu, N
    Sheppard, H
    Hahn, BH
    Allen, S
    Frelinger, JA
    [J]. JOURNAL OF VIROLOGY, 1997, 71 (11) : 8908 - 8911
  • [3] Multiple blocks to human immunodeficiency virus type 1 replication in rodent cells
    Bieniasz, PD
    Cullen, BR
    [J]. JOURNAL OF VIROLOGY, 2000, 74 (21) : 9868 - 9877
  • [4] VIRUS-SPECIFIC CD8+ CYTOTOXIC T-LYMPHOCYTE ACTIVITY ASSOCIATED WITH CONTROL OF VIREMIA IN PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION
    BORROW, P
    LEWICKI, H
    HAHN, BH
    SHAW, GM
    OLDSTONE, MBA
    [J]. JOURNAL OF VIROLOGY, 1994, 68 (09) : 6103 - 6110
  • [5] Vaccination of seronegative volunteers with a human immunodeficiency virus type 1 env/rev DNA vaccine induces antigen-specific proliferation and lymphocyte production of β-chemokines
    Boyer, JD
    Cohen, AD
    Vogt, S
    Schumann, K
    Nath, B
    Ahn, L
    Lacy, K
    Bagarazzi, ML
    Higgins, TJ
    Baine, Y
    Ciccarelli, RB
    Ginsberg, RS
    MacGregor, RR
    Weiner, DB
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2000, 181 (02) : 476 - 483
  • [6] In vivo protective anti-HIV immune responses in non-human primates through DNA immunization
    Boyer, JD
    Wang, B
    Ugen, KE
    Agadjanyan, M
    Javadian, A
    Frost, P
    Dang, KS
    Carrano, RA
    Ciccarelli, R
    Coney, L
    Williams, WV
    Weiner, DB
    [J]. JOURNAL OF MEDICAL PRIMATOLOGY, 1996, 25 (03) : 242 - 250
  • [7] Immunostimulatory CpG motifs trigger a T helper-1 immune response to human immunodeficiency virus type-1 (HIV-1) gp160 envelope proteins
    Deml, L
    Schirmbeck, R
    Reimann, J
    Wolf, H
    Wagner, R
    [J]. CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 1999, 37 (03) : 199 - 204
  • [8] DNA vaccines
    Donnelly, JJ
    Ulmer, JB
    Shiver, JW
    Liu, MA
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 1997, 15 : 617 - 648
  • [9] Cross-reactions between the cytotoxic T-lymphocyte responses of human immunodeficiency virus-infected African and European patients
    Durali, D
    Morvan, J
    Letourneur, F
    Schmitt, D
    Guegan, N
    Dalod, M
    Saragosti, S
    Sicard, D
    Levy, JP
    Gomard, E
    [J]. JOURNAL OF VIROLOGY, 1998, 72 (05) : 3547 - 3553
  • [10] Feltquate DM, 1997, J IMMUNOL, V158, P2278